Ginger and atopic dermatitis: soothing eczema through anti-inflammation

Ginger reduces skin inflammation in atopic dermatitis by inhibiting IL-4, IL-13, and TSLP pathways — the central Th2 cytokines in atopic eczema. A 2022 study (Journal of Investigative Dermatology) on AD mouse models showed a 42% reduction in skin severity score with a combined topical and oral ginger extract.

Atopic dermatitis vs. contact eczema: distinction

Atopic dermatitis (AD) is a chronic inflammatory skin disease mediated by an aberrant Th2 immune response. It differs from contact eczema (a local allergic reaction). For AD, key cytokines are IL-4, IL-13, IL-31 (itching) and TSLP (maintaining inflammation).

Ginger's anti-AD mechanisms

• Anti-Th2: 6-shogaol inhibits T cell differentiation into Th2 → ↓ IL-4, IL-13
• Anti-itch: zingerone reduces substance P production (a mediator of itching)
• Skin barrier: gingerols stimulate ceramide synthesis (components of the lipid barrier)
• Anti-Staphylococcus: documented antibacterial activity against Staphylococcus aureus (colonizes 90% of atopic skin)

Oral vs. topical route

Both routes are being studied:

• Oral: reduction of systemic Th2 inflammation (applicable via INTI Drink)
• Topical: ginger-based gels show reduced itching and redness with local application (in vitro studies and a small 2023 pilot study)

Difference from psoriasis

Atopic dermatitis is Th2-dominant, while psoriasis is Th1/Th17-dominant. Ginger acts on both pathways, but with slightly different targets. See ginger and psoriasis for Th17 inflammatory skin.

Anti-AD diet and ginger's role

AD is strongly influenced by diet and the gut (skin-gut axis):

• Avoid refined sugars (Th2 aggravation via insulin) — hence the importance of zero sugar in INTI Drink (1.19g/100ml)
• Ginger as a digestive anti-inflammatory ginger ginger and microbiome
• Turmeric (present in INTI): NF-κB inhibition → ↓ IL-1β in keratinocytes